ESC – Page 13 – Clinical Trial Results

Dr. Pascal Vranckx and Dr. C. Michael Gibson Discuss: ENTRUST-AF PCI – Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.

September 3, 2019

Disclosures: TBA

Dr. Satoshi Yasuda and Dr. Arzu Kalayci Discuss: AFIRE – Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

September 2, 2019

Disclosures: TBA

Dr. John J.P. Kastelein and Dr. C Michael Gibson Discuss: Why Are Patients Not Achieving the LDL Goals? – Sponsored by an independent educational grant from The Medicines Company

September 2, 2019

Sponsored by an independent educational grant from The Medicines Company

Dr. James Januzzi and Dr. C. Michael Gibson Discuss: Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on NT-proBNP and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: Primary Results of the PROVE-HF Study

September 2, 2019

Disclosures: TBA

Dr. Basil Lewis and Dr. Yoseph Rozenman Present: ESC 2019 Wrap-Up in Hebrew

September 2, 2019

Disclosures: TBA

Dr. Hisao Ogawa Presents: ESC 2019 Wrap-Up in Japanese

September 2, 2019

Disclosures: TBA

Dr. Jose Luis Leiva Pons and Dr. Xavier Escudero Present: ESC 2019 Wrap-Up in Spanish

September 2, 2019

Disclosures: TBA

Dr. JD Schwalm and Dr. Adam T. Phillips Discuss: HOPE 4 – Impact on cardiovascular risk of a community-based multi-faceted intervention in individuals with hypertension in 2 middle income countries: The Heart Outcomes Prevention and Evaluation 4 study

September 2, 2019

Disclosures: TBA

Dr. Robert Byrne and Dr. Mamas Mamas Present: ESC 2019 Wrap-Up from the UK/Ireland Perspective

September 2, 2019

Disclosures: TBA

Dr. Dragos Vinereanu and Dr. Dan Gaita Present: ESC 2019 Wrap-Up in Romanian

September 2, 2019

Disclosures: TBA